期刊文献+

甲型H1N1流行性感冒疫苗上市后预防接种不良反应特征分析 被引量:4

Analysis on characteristics of post-marketing adverse reaction following influenza A(H1N1) vaccine immunization
原文传递
导出
摘要 目的分析大规模人群应用甲型H1N1流行性感冒疫苗后的预防接种不良反应特征,进一步观察该疫苗的安全性。方法通过国家疑似预防接种异常反应监测系统,收集广州市2009年10月28日~2010年8月31日期间的甲型H1N1流感疫苗接种信息和接种后疑似预防接种不良反应个案数据,分析相关特征。结果共接种575 412人,报告183例预防接种不良反应,不良反应发生率为31.80/10万,其中异常反应发生率为5.39/10万;52.5%的不良反应发生在接种疫苗后24 h内,以发热、红肿多见,多数不良反应预后良好。接种疫苗后出现急性播散性脑脊髓炎2例,为13岁及15岁男孩各1名,其中1例死亡。结论大规模接种甲型H1N1流感疫苗后预防接种不良反应的发生率低,但需警惕严重不良反应的发生。 Objective To analyze the characteristics of post licensure adverse reaction following influenza A(H1N1) vaccine immunization and to observe the further safety.Methods Relevant data were collected from National Immunization Information System.Data during Oct 28th 2009 to Aug 31th 2010 in Guangzhou were analyzed.Results 575 412 immunization cases were reported,including 183 cases with adverse reactions following immunization,with the incidence rate of 31.8 and rare adverse reaction of 5.39 per 100 000 doses.52.5% of reactions occurred within 24 hours post-vaccination.The clinical features of adverse reaction following influenza A(H1N1) vaccine immunization primarily included fever,local redness and swelling;however,all the cases exhibited improved prognosis.Two boys aged 13 and 15 respectively were diagnosed as acute disseminated encephalomyelitis following influenza A(H1N1) vaccination.Conclusions A low incidence rate of adverse reaction following influenza A(H1N1) vaccine immunization was observed in the large scale inoculation,however,monitoring for serious adverse reactions is recommended.
出处 《中华疾病控制杂志》 CAS 北大核心 2012年第2期145-148,共4页 Chinese Journal of Disease Control & Prevention
基金 广东省医学科研基金(A2011506) 广州市医药卫生科技项目(201102A213026)
关键词 流感疫苗 接种 监测 免疫学 流行病学研究 Influenza vaccine Vaccination Monitoring immunologic Epidemiologic studies
  • 相关文献

参考文献11

  • 1Stone R. China first to vaccinate against novel HINI virus [J]. Science, 2009,325(5947) : 1482-1483.
  • 2Liang XF, Wang HQ, Wang JZ, et al: Safety and immunogenici ty of 2009 pandemic influenza A HIN1 vaccines in China: a muki centre, double-blind, randomised, placetx>controled trial[J].Lancet, 2010,375(9708) : 56 66.
  • 3Fu C. Effectiveness of HINI vaccine against retmrted lnflueta A (H1N1): Southern China, October 2009-February 2010LJa.r q Hum Vaccin, 2010,6(9). [Epub ahead of printS.
  • 4Wu J, Xu F, Lu L, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing [J]. N Engl J Med, 2010,363(25): 2416-2423.
  • 5Fu C, Wang M, Liang J, et al. The effectiveness of varicella vac- cine in China [J]. Pediatr Infect Dis J, 2010,29(8):690-693.
  • 6Fu C, Wang M, Liang J, et al. Effectiveness of Lanzhou laml0 rotavirus vaccine against rotavirus gastroenteritis requiring hospi- talization: a matched case-control study [J ]. Vaccine, 2007,25 (52) :8756-8761.
  • 7张伟伟,李亮,朱凤才,修仕信.甲型H_1N_1流行性感冒疫苗研究进展及不良反应监测[J].中国疫苗和免疫,2010,16(3):275-278. 被引量:3
  • 8焦兰萍,贺志莉,王川,宋海玲.疫苗接种后急性播散性脑脊髓炎2例[J].实用儿科临床杂志,2003,18(12):965-965. 被引量:9
  • 9吴冰冰,刘大卫,李克莉,武文娣,许涤沙,贾磊.甲型H_1N_1流行性感冒疫苗安全性监测初步分析评价[J].中国疫苗和免疫,2010,16(5):385-392. 被引量:10
  • 10陈恩富,胡昱,凌罗亚,李倩,陈雅萍,戚小华,陈永弟.甲型H_1N_1流感疫苗的疑似预防接种异常反应监测[J].浙江预防医学,2010,22(5):1-3. 被引量:22

二级参考文献42

  • 1梁雁,张海燕,鲁云兰,崔一民.流感疫苗安全性的调查[J].药物不良反应杂志,2005,7(2):95-97. 被引量:19
  • 2高波廷.急性播散性脑脊髓炎[A].见:方思羽.神经内科疾病指南[C].北京:科学出版社,1999.547~548.
  • 3吴希如 李万镇.临床儿科学[M].北京:科学出版社,2005.1639-1640.
  • 4European Medicines Agency.Fifth pandemic pharmacovigilance weekly update[R].www.emea.europa.eu,6 January 2010.
  • 5Medicine and Healthcare Products Regulatory Agency.Suspected Adverse Drug Reaction(ADR) Analysis:Swine Flu Vaccines-H1N1(Celvapan and Pandemrix)[R].www.mhra.gov.uk,5 March 2009.
  • 6XiaoFeng Liang,HuaQing Wang,JunZhi Wang,et al.Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:a multicentre,double-blind,randomised,placebo-controlled trial[J].Lancet,2010,375(9708):56-66.
  • 7FengCai Zhu,Hua Wang,HanHua Fang,et al.A Novel Influenza A (H1N1) Vaccine in Various Age Groups[J].N Engl J Med,2009,361(25):2414-2423.
  • 8Izurieta HS,Haber P,Wise RP,et al.Adverse events reported following live,cold-adapted,intranasal influenza vaccine[J].JAMA,2005,294(21):2720-2725.
  • 9CDC.Update:infections with a swine-origin influenza A (HiNl)virus-- United States and other countries [J]. MMWR, 2009, 58 (16) : 431-433.
  • 10]Nicole Lurie, MD, MS. PH. H1N1 Influenza, Public Health Preparedness,and HealthCare Reform[J]. NEMJ, 2009, 361 (9) : 843-845.

共引文献38

同被引文献57

  • 1张丽洁,王远红,武翠玲,班瑞.预防接种疫苗不良反应二例分析[J].中国全科医学,2013,16(8):938-939. 被引量:18
  • 2满玉红,于挺敏,吴杰,管姝轶.Fisher综合征研究进展[J].中国实验诊断学,2005,9(4):654-655. 被引量:5
  • 3Lu S,Wang S,Grimes-Serrano JM.Current progress of DNA vaccine studies in humans[J].Expert Rev Vaccines,2008,7(2):175-191.
  • 4Deem MW,Pan K.The epitope regions of H1-subtype influenza A,with application to vaccine efficacy[J].Prot Eng Des Sel,2009,22(9):543-546.
  • 5Wu J,Xu F,Lu L,et al.Safety and Effectiveness of a 2009H1N1 Vaccine in Beijing[J].N Engl J Med,2010,363 (25):2416-2423.
  • 6Baras B,de Waal L,Stittelaar KJ,et al.Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets[J].Vaccine,2011,29(11):2120-2126.
  • 7Baxter R,Toback SL,Sifakis F,et al.A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age[J].Vaccine,2012,30 (20):3053-3060.
  • 8Mayet A,Ligier C,Gache K,et al.Adverse events following pandemic influenza vaccine Pandemrix(R) reported in the French military forces 2009-2010[J].Vaccine,2011,29(14):2576-2581.
  • 9Sarntivijai S,Xiang Z,Shedden KA,et al.Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines[J].PLoS One,2012,7(11):e49941.
  • 10Vellozzi C,Broder KR,Haber P,et al.Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse event reporting System,United States,October 1,2009-January 31,2010[J].Vaccine,2010,28 (45):7248-7255.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部